A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

Frontal Fibrosing Alopecia Clinical Trial

Official title:
A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled, Single Site, Exploratory Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

Status Completed

Clinical Trial Summary

This purpose of this trial is to investigate the molecular signature of frontal fibrosing alopecia (FFA) and the effect of delgocitinib cream 2% on reversing the FFA disease signature in active lesions. The trial will also investigate the clinical effect of delgocitinib cream on FFA compared to a placebo cream.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05332366
Study type	Interventional
Source	LEO Pharma
Contact
Status	Completed
Phase	Phase 2
Start date	April 19, 2022
Completion date	May 22, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04409041` - Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia	Phase 2
Completed	`NCT03630198` - Pain Outcomes Following Intralesional Corticosteroid Injections	Phase 4
Enrolling by invitation	`NCT06202560` - Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study	N/A
Not yet recruiting	`NCT03335228` - Platelet Rich Plasma for Frontal Fibrosing Alopecia	N/A
Not yet recruiting	`NCT06240351` - A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)	Phase 4
Not yet recruiting	`NCT02467101` - Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia	N/A
Recruiting	`NCT03422640` - Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia	Phase 4
Completed	`NCT03346668` - Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia	Early Phase 1
Active, not recruiting	`NCT03082560` - Design and Validation of a New Assessment Tool for Lichen Planopilaris
Completed	`NCT04342091` - Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling	N/A